Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptors

Neuroscience

Volumn 114, Issue 3, 2002, Pages 523-527

  Wu, W P ^a   Hao, J X ^a   Halldner Henriksson, L ^a   Xu, X J ^a   Jacobson, M A ^b   Wiesenfeld Hallin, Z ^a   Fredholm, B B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Nociception; Pain; Plasma extravasation; R PIA; Spinal cord

Indexed keywords

ADENOSINE A3 RECEPTOR; CARRAGEENAN; PHENYLISOPROPYLADENOSINE;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXTRAVASATION; HEAT; HYPERALGESIA; INFLAMMATION; MECHANICAL STIMULATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PAW EDEMA; PRIORITY JOURNAL;

ANIMALS; CARRAGEENAN; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1;

EID: 0037063720     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00273-7     Document Type: Article

References (26)

1. Al-Haboubi H.A., Zeitlin I.J. Re-appraisal of the role of histamine in carrageenan-induced paw oedema. Eur. J. Pharmacol. 88:1983;169-176.
2. Baraldi P.G., Cacciari B., Romagnoli R., Merighi S., Varani K., Borea P.A., Spalluto G. A3 adenosine receptor ligands: history and perspectives. Med. Res. Rev. 20:2000;103-128.
3. Damas J., Remacle-Volon G. Mast cell amines and the oedema induced by zymosan and carrageenan in rats. Eur. J. Pharmacol. 121:1986;367-376.
4. Ezeamuzie C.I., Umezurike C.C. Effect of histamine H2-receptor antagonists on acute inflammatory of the rat paw oedema. J. Pharm. Pharmacol. 41:1989;261-265.
5. Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., Linden, J., 2000. Adenosine receptors. In: Girdlestone, D. (Ed.), The IUPHAR Compendium of Receptor Characterization and Classification. IUPHAR Media, London, pp. 78-87.
6. Guo Y., Mochizuki T., Morii E., Kitamura Y., Maeyama K. Role of mast cell histamine in the formation of rat paw edema: a microdialysis study. Eur. J. Pharmacol. 331:1997;237-243.
7. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
8. 3-adenosine receptors in mediation of behavioral depressant effects. FEBS Lett. 336:1993;57-60.
9. Johansson B., Halldner L., Dunwiddie T.V., Masino S., Poelchen W., Giménez-Llort l., Escorihuela R.M., Fernández-Teruel A., Wiesenfeld-Hallin Z., Xu X.-J., Herlenius E., Härdemark A., Betsholtz C., Fredholm B.B. Anxiety, hyperalgesia and decreased response to hypoxia in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. USA. 98:2001;9407-9412.
10. Klotz K-N., Hessling J., Hegler J., Owman C., Kull B., Fredholm B.B., Lohse M.J. Comparative pharmacology of human adenosine receptor subtypes: characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 357:1998;1-9.
11. Koltzenburg M., Wall P.D., McMahon S.B. Does the right side know what the left is doing? Trends Neurosci. 22:1999;122-127.
12. Ledent C., Vaugeois J.M., Schiffmann S.N., Pedrazzini T., El Yacoubi M., Vanderhaeghen J.J., Costentin J., Heath J.K., Vassart G., Parmentier M. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2A receptor. Nature. 388:1997;674-678.
13. Linden J. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 15:1994;298-306.
14. Neil A., Benoist J.M., Kayser V., Guilbaud G. Initial nociceptive sensitization in carrageenin-induced rat paw inflammation is dependent on amine autacoid mechanisms: electrophysiological and behavioral evidence obtained with a quaternary antihistamine, thiazinamium. Exp. Brain Res. 65:1987;343-351.
15. Patwardhan M.D., Muley M.P., Manekar M.S. Anti-inflammatory property of ranitidine, a specific H2-receptor antagonist. Indian J. Physiol. Pharmacol. 30:1986;205-209.
16. 3 adenosine receptor is the uniauq adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268:1993;16887-16890.
17. Rouleau A., Stark H., Schunack W., Schwartz J.C. Anti-inflammatory and antinociceptive properties of BP2-94, a histamine H(3)-receptor agonist prodrug. J. Pharmacol. Exp. Ther. 295:2000;219-225.
18. 3 adenosine receptors. J. Immmunol. 156:1996;3435-3442.
19. 3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J. Biol. Chem. 275:2000;4429-4434.
20. Sawynok J. Adenosine receptor activation and nociception. Eur. J. Pharmacol. 347:1998;1-11.
21. Sawynok J., Reid A., Liu X.J. Acute paw oedema induced by local injection of adenosine A(1), A(2) and A(3) receptor agonists. Eur. J. Pharmacol. 386:1999;253-261.
22. 3 receptor activation produces nociceptive behavior and edema by release of histamine and 5-hydroxytryptamine. Eur. J. Pharmacol. 333:1997;1-7.
23. Sin Y.M., Sedgwick A.D., Chea E.P., Willoughby D.A. Mast cells in newly formed lining tissue during acute inflammation: a six day air pouch model in the mouse. Ann. Rheum. Dis. 45:1986;873-877.
24. Stochla K., Maslinski S. Carrageenan-induced oedema in the rat paw - histamine participation. Agents Actions. 12:1982;201-202.
25. Tilley S.L., Wagoner V.A., Salvatore C.A., Jacobson M.A., Koller B.H. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J. Clin. Invest. 105:2000;361-367.
26. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA. 89:1992;7432-7436.